Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children’s Oncology Group
Yousif Matloub(Roswell Park Comprehensive Cancer Center), Paul S. Gaynon(University of Southern California), Karen R. Rabin(Children's Cancer Center), Lingyun Ji(University of Southern California), Stephen P. Hunger(Children's Hospital of Philadelphia), Xinxin Xu(Henan Normal University), Johann Hitzler(University of Toronto), Naomi Winick(The University of Texas Southwestern Medical Center), Eileen Stonerock(Nationwide Children's Hospital), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Linda C. Stork(Oregon Health & Science University), Bruce Bostrom(Minnesota West Community & Technical College), Nyla A. Heerema(The Ohio State University), Julie M. Gastier‐Foster(Nationwide Children's Hospital)
Cited by 36
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k